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The inﬂuenza hemagglutinin (HA) glycoprotein plays a critical role
in initiating cellular infection by recognizing sialic acid (SA) expressed
on cell surface glycoproteins and glycolipids (reviewed by Skehel and
Wiley, 2000). The globular head of HA contains the receptor-binding
site (RBS), a shallow pocket of highly conserved amino acids that
interact with sialylated receptors. In nature, SA is generally attached
to the penultimate galactose residues of oligosaccharide side chains
by α(2,3)-Gal or α(2,6)-Gal linkages (Skehel and Wiley, 2000). The
HA of human inﬂuenza viruses shows a preference for binding to
α(2,6)-Gal-linked SA (Connor et al., 1994; Rogers and Paulson, 1983),
which is abundantly expressed on non-ciliated cells in the human
respiratory tract (Matrosovich et al., 2004). In contrast, avian
inﬂuenza viruses prefer α(2,3)-Gal-linked SA which is expressed on
epithelial cells in the gastro-intestinal tract of numerous avian species,
including chickens, turkeys andmigratory ducks (Ito et al., 1998; Pillai
and Lee, 2010).
Amino acids in and around the RBS of HA determine the speciﬁc SA
linkages that will be recognized by a particular virus strain. Although
the RBS is structurally conserved among a number of HA subtypes,
studies have identiﬁed speciﬁc residues directly within, as well as in
the vicinity of the RBS, that are critical for SA binding and receptorspeciﬁcity (reviewed by Russell et al., 2006; Skehel and Wiley, 2000).
In particular, amino acids 145 (Matrosovich et al., 1998; Ryan-Poirier
and Kawaoka, 1991), 186 (Gambaryan et al., 1999; Matrosovich et al.,
1998; Matrosovich et al., 1997; Widjaja et al., 2006), 190 (Gambaryan
et al., 1999; Nobusawa et al., 2000), 193 (Medeiros et al., 2001;
Medeiros et al., 2004), 225 (Matrosovich et al., 1997), 226 (Pekosz
et al., 2009; Vines et al., 1998) and 228 (Matrosovich et al., 1997;
Pekosz et al., 2009; Vines et al., 1998) are important in modulating the
receptor speciﬁcity of H3 subtype viruses.
Mice are not naturally infected with inﬂuenza virus and intranasal
inoculation with human inﬂuenza viruses generally does not result in
severe disease (Hawgood et al., 2004; Reading et al., 1997; Sweet and
Smith, 1980; Vigerust et al., 2007), although H5N1 viruses and the 1918
pandemic H1N1 virus induce disease in mice without prior adapta-
tion (Gao et al., 1999; Perrone et al., 2008; Tumpey et al., 2005). Se-
quential passage of human isolates in mouse lung results in selection of
virus mutants with increased replication efﬁciency that are capable
of inducing viral pneumonia similar to that observed in humans (Sweet
and Smith, 1980). In the lower respiratory tract of mice, the expres-
sion of α(2,3)-Gal-linked SA predominates over α(2,6)-Gal-linked SA
(Glaser et al., 2007; Ning et al., 2009). Adaptation of human inﬂuenza
viruses to growth in mouse lung can be associated with a switch in
receptor speciﬁcity to enhance binding to α(2,3)-Gal-linked SA
(Hensley et al., 2009; Keleta et al., 2008; Smeenk et al., 1996).
Surfactant protein (SP)-D is an innate immune protein of the
collectin superfamily present in airway secretions that binds to
mannose-rich glycans on inﬂuenza virus HA and/or neuraminidase
(NA) to mediate a range of antiviral activities (reviewed by Crouch
Table 1
Receptor speciﬁcity of BJx109 mutant viruses.
Virus Hemagglutination titera
Native Asialo α(2,3)-SA α(2,6)-SA
BJWT 64 b1 b1 32
BJpp1 64 b1 32 32
BJpp2 64 b1 32 32
BJpp3 64 b1 32 32
PR8 64 b1 32 b1
a BJWT, BJpp1-BJpp3 or PR8 viruses were compared for their ability to agglutinate
desialylated and enzymatically resialylated erythrocytes. Human erythrocytes were
desialylated with bacterial sialidase from C. perfringens for 1 h at 37 °C and
enzymatically resialylated with Neu5Ac in the presence of either α(2,3)-sialyltransfer-
ase or α(2,6)-sialyltransferase as described in Materials and methods. Native human
erythrocytes were included for comparison. HA assays were performed using standard
procedures and data are expressed as HAU. PR8 was included due to its known
speciﬁcity for α(2,3)-Gal-linked SA.
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the sensitivity of different inﬂuenza viruses to neutralization by SP-D
and their ability to replicate in mouse lung. Highly glycosylated virus
strains that were neutralized by SP-D did not replicate efﬁciently in
the lungs of immunocompetent mice (Reading et al., 1997; Vigerust
et al., 2007), but replicated to high titers in SP-D-knockout mice
(Vigerust et al., 2007). β-Inhibitors in mammalian serum and lung
ﬂuids are mannose-binding lectins of the collectin superfamily
(Anders et al., 1990) and adaptation of human H1 viruses to growth
in mouse lung was associated with development of resistance to β-
inhibitors (Briody et al., 1955; Chu, 1951; Shilov and Sinitsyn, 1994).
Furthermore, β-resistant H3 subtype viruses selected in the presence
of bovine serum (a rich source of the bovine collectin conglutinin)
showed enhanced virulence in mice (Hartley et al., 1997). Additional
factors, including changes in HA/NA balance (Wagner et al., 2002) and
point mutations in genes encoding internal components of the virion,
including PB1-F2 (Conenello et al., 2007), M1 (Brown et al., 2001;
McCullers et al., 2005) and polymerase genes (Gabriel et al., 2005;
Hatta et al., 2001), also contribute to virulence in mice.
We have recently demonstrated that depletion of airway macro-
phages (Mϕ) during infection of C57BL/6 mice with the virus strain
BJx109 (H3N2) was associated with enhanced disease severity,
characterized by increased virus replication and pulmonary inﬂam-
mation (Tate et al., 2010b). Plaques formed on MDCK cell monolayers
inoculated with lung homogenates from BJx109-infected mice de-
pleted of Mϕ (via intranasal treatments with clodronate-loaded
liposomes (CL-LIP)) were plaque-puriﬁed, ampliﬁed once in eggs and
used to inoculate untreated C57BL/6 mice. Each of the plaque-puriﬁed
viruses showed enhanced virulence in mice. The studies described
herein have investigated the mechanism/s underlying the enhanced
virulence of BJx109 viruses in mice.
Results
Isolation of virus mutants of BJx109 from the lungs of mice depleted of
Mϕ
In a previous study, we examined the role of Mϕ following in-
fection of mice with inﬂuenza virus BJx109 (Tate et al., 2010b).
Treatment of virus-infected mice with saline-loaded liposomes
(SL-LIP) was associated with mild disease, whereas treatment of
mice with CL-LIP (to deplete airway Mϕ) led to progressive weight
loss and death. At day 7 post-infection, lungs from BJx109-infected
mice treated with CL-LIP were plaqued on MDCK cell monolayers. No
infectious virus was recovered from the lungs of SL-LIP-treated mice
at this time, whereas high levels of virus were recovered from mice
treated with CL-LIP (log10PFU 4.63±0.03) and 5 plaques (from 3
different mice) were picked, ampliﬁed once in eggs and analyzed.
Allantoic ﬂuid containing either wild-type BJx109 (BJWT; as used for
intranasal inoculation of mice) or plaque-puriﬁed BJx109 (BJpp1-BJpp5)
were inoculated onto MDCK cell monolayers and plaque size was
determined 3 days later. BJpp1-BJpp5 formed plaques that were smaller
(~200 μm diameter from 10 individual plaques per sample) than BJWT
(~1000 μm). These differences in plaque size were likely to reﬂect
differences in the properties of the HA and/or NA glycoproteins of the
virus as these play a major role in facilitating the cell to cell spread of
virus (Baigent and McCauley, 2001; Suzuki et al., 2005).
The small plaque phenotype of BJx109 mutant viruses is associated with
a single amino acid change in HA
RNA was extracted from allantoic ﬂuid containing BJWT and BJpp1-
BJpp5 and the HA and NA genes were ampliﬁed by PCR, sequenced and
aligned. The deduced amino acid sequence of the NA from BJWT and
BJpp1-BJpp5 was identical. In contrast, each small plaquemutant differed
fromBJWTby a singlebase substitution (A814→T) inHA1,which resultedin substitution of Ser with Ile at residue 186 (S186I). Residue 186 is
located on the head of HA in the vicinity of the RBS but does not directly
interact with SA. However, it does interact with residues 190 and 228,
which form hydrogen bonds with the C9 hydroxyl group of the
polyhydroxyl tail of Neu5Ac and thus mutations at this position have
potential to indirectly alter the conformation of the receptor-binding
site (Eisen et al., 1997; Sauter et al., 1992; Weis et al., 1988). BJx109
viruses carrying the S186I substitution will be referred to hereafter as
BJ186.
BJ186 mutants show an enhanced ability to recognize α(2,3)-Gal-linked
SA
Amino acid changes in the RBS of HA are associated with dif-
ferences in ability to bind α(2,3)-Gal and α(2,6)-Gal-linked SA
(reviewed by Russell et al., 2006; Skehel and Wiley, 2000). Therefore,
to assess receptor speciﬁcity we ﬁrst compared BJWT and BJ186 for their
ability to agglutinate erythrocytes from different species. No major
differences were observed in the ability of viruses to agglutinate
human, chicken, turkey or guinea pig erythrocytes (data not shown),
which express differing levels of α(2,3)-Gal-linked and α(2,6)-Gal-
linked SA (Ito et al., 1997a; Medeiros et al., 2001). Horse erythrocytes
express only α(2,3)-Gal-linked Neu5Gc (Eylar et al., 1962; Ito et al.,
1997a; Suzuki et al., 1985) and were agglutinated by BJ186 (HAU=4–
8 HAU), but not by BJWT (HAU=b1).
Next, human erythrocyteswere desialylated using bacterial sialidase
and enzymatically resialylated to express either α(2,3)-Gal- or α(2,6)-
Gal-linked Neu5Ac. BJWT agglutinated erythrocytes expressing α(2,6)-
Gal-, but not α(2,3)-Gal-linked Neu5Ac (Table 1). In contrast, BJ186
viruses agglutinated erythrocytes bearing either α(2,3)-Gal or α(2,6)-
Gal-linkedNeu5Ac, suggesting that S186I results in enhanced binding to
α(2,3)-Gal-linkedNeu5Ac,while retainingbinding toα(2,6)-Gal-linked
Neu5Ac. An additional property of the viral HA that could inﬂuence
the efﬁciency of viral replication and therefore virulence is the pH at
which fusion of the viral envelope with the endosomal membrane
occurs. Using themethod of Doms et al. (1986), we did not observe any
signiﬁcant differences in the optimal pH atwhich BJWT and BJ186 viruses
mediated lysis of human erythrocytes (data not shown).
Enhanced ability of BJ186 to bind and infect murine airway epithelial cells
To investigate whether changes in receptor speciﬁcity of BJ186
viruses impacted on ability to infect epithelial cells, monolayers of
LA-4 cells (a mouse airway epithelial cell line (Stoner et al., 1975))
were infected with increasing doses of BJWT or BJ186 and, after 1 h,
monolayers were washed, incubated for 7 h and ﬁxed and stained by
immunoﬂuorescence for expression of viral NP (Fig. 1A). At a high
inoculum dose (106 PFU), BJWT and BJ186 viruses infected LA-4 cells
Fig. 1. Enhanced ability of BJ186 to bind and infect mouse LA-4 epithelial cells.
(A) Monolayers of LA-4 cells were incubated with increasing doses of BJWT or BJpp1-
BJpp3 viruses. After 1 h, monolayers were washed, incubated a further 7 h and ﬁxed and
stained by immunoﬂuorescence for expression of newly synthesized viral NP.
(B) Monolayers of LA-4 cells were incubated with 106 PFU of BJWT or BJpp1-BJpp3
viruses for 5 min, washed, and incubated a further 7 h. At this time, cells were ﬁxed and
stained by immunoﬂuorescence for expression of viral NP. Data in A/B represent the
mean percent infection (±1 SD) from aminimum of 4 independent ﬁelds per chamber.
*=BJWT is signiﬁcantly reduced compared to all other groups, pb0.01, one-way
ANOVA. (C) Ability of viruses to bind to and elute from the epithelial cell surface.
Duplicate tubes of formaldehyde-ﬁxed LA-4 epithelial cells were mixed with 128 HAU
of each virus for 1 h on ice. After virus adsorption, one sample was held at 4 °C (‘4°C’),
while the duplicate tube was transferred to 37 °C for 30 min (‘37°C’). A third tube with
no cells received virus alone (‘Control’) and was held on ice throughout. Following
centrifugation, virus in each of the supernatants was quantiﬁed by hemagglutination
assay. Data shown are the mean±1 SD HAU from 3 independent experiments.
(D) Monolayers of LA-4 cells were infected with 0.01 PFU/cell of BJWT or BJpp1 virus and
at time-points indicated, cell supernatants were removed and clariﬁed, and titers of
infectious virus in cell supernatants were determined by plaque assay on MDCK cells.
Data represent the mean virus titer±1 SD from triplicate samples and are
representative of 2 independent experiments. *=signiﬁcantly different to BJWT virus,
pb0.05, Student's t test.
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viruses infected cells more efﬁciently. These ﬁndings are consistent
with reports that α(2,3)-Gal-linked SA is the predominant linkage
expressed on murine airway epithelial cells (Glaser et al., 2007; Ning
et al., 2009) and with our ﬁndings that the α(2,3)-Gal-speciﬁc plant
lectinMaackia amurensis agglutinin (MAA) binds more avidly to LA-4
cells than α(2,6)-Gal-speciﬁc Sambucus nigra agglutinin (SNA) (Tate
et al., 2011).
Next, we investigated if reducing the time of exposure to virus
inoculum might also reveal differences in the ability of BJWT and BJ186
to infect epithelial cells. LA-4 cells were incubated for 5 min with 106
PFU of BJWT or BJ186, washed and the percent of virus-infected cells
was determined 8 h later. Incubation of cells with BJWT inoculum for
60 min resulted in ~90% infection of LA-4 cells (Fig. 1A), whereas
inoculation with an equivalent dose for 5 min resulted in ~40%
infection (Fig. 1B). In contrast, inoculation of LA-4 cells with 106 PFU
of BJ186 viruses for either 60 min (Fig. 1A) or 5 min (Fig. 1B) resulted
in equivalent (~90%) levels of infection. Thus, S186I is associated with
enhanced ability to infect murine airway epithelial cells.
As the balance of HA and NA activity can affect the efﬁciency of
virus entry (Wagner et al., 2002), we next compared the ability of
viruses to bind and elute from the surface of LA-4 epithelial cells. All
viruses bound efﬁciently to paraformaldehyde-ﬁxed LA-4 cells at 4 °C
(as indicated by a reduced HA titer) but differed in their ability to
elute from the cell surface when shifted to 37 °C (Fig. 1C). BJWT eluted
efﬁciently from LA-4 cells at 37 °C; however, BJ186 viruses were not
released. Thus, BJ186 viruses bind more avidly to LA-4 cells such that
the activity of the viral NA is less effective at releasing virus from the
cell surface.
We usedmultistep growth curves to compare the ability of BJWT and
BJ186 to replicate in LA-4 cells (Fig. 1D). Although BJ186 viruses were
more efﬁcient in their ability to infect LA-4 cells, levels of infectious virus
in cell supernatants at 16, 24 and 48 h were signiﬁcantly reduced
compared to BJWT in 2 independent experiments.
Reduced ability of BJ186 to infect murine airway Mϕ
Inﬂuenza A virus infection of airway epithelial cells results in pro-
ductive virus replication. In contrast, infection of mouse Mϕ is gen-
erally a component of innate defense as virus replication is abortive
and Mϕ respond by secreting pro-inﬂammatory mediators (Hofmann
et al., 1997; Rodgers and Mims, 1981; Tate et al., 2010b; Wells et al.,
1978), although some humanMϕ populations can support productive
infection (Cheung et al., 2002; Perrone et al., 2008). Murine Mϕ
express predominantly α(2,6)-Gal-linked SA and the preference of
BJx109HA forα(2,6)-Gal-linked SA is an important factor contributing
to its ability to infect Mϕ efﬁciently (Tate et al., 2011). We hy-
pothesized that the changes in receptor preference of BJ186 viruses
might also affect their ability to infect murine Mϕ. As airway Mϕ and
peritoneal Mϕ show a similar susceptibility to infection by different
inﬂuenza A viruses (Reading et al., 2000; Reading et al., 2010; Tate
et al., 2010b), we compared the ability of BJWT and BJ186 viruses to
infect adherence-puriﬁed peritoneal Mϕ. At all inoculum doses tested,
BJ186 viruses were less efﬁcient in their ability to infect Mϕ (Fig. 2A).
Furthermore, when the exposure to inoculum was reduced from
60 min (Fig. 2A) to 5 min (Fig. 2B), BJWT was again more efﬁcient than
BJ186 in mediating infection of Mϕ.
Neutralization of BJWT and BJ186 viruses by mouse BAL
The HA of BJx109 is highly glycosylated and this virus is very sen-
sitive to SP-D-mediated neutralization (Reading et al., 1997). Previous
studies have demonstrated that loss of glycan/s from HA leads to
increased resistance to SP-D and enhanced virulence in mice (Hartley
et al., 1997; Hawgood et al., 2004; Reading et al., 2009; Vigerust et al.,
2007). As SP-D represents the major neutralizing activity in mouse
Fig. 2. BJ186 viruses show reduced ability to infect murineMϕ. (A) Monolayers of PEC Mϕ
were incubatedwith increasing doses of BJWT or BJpp1- BJpp3 viruses. After 1 h,monolayers
werewashed, incubated a further 7 h and then ﬁxed and stained by immunoﬂuorescence
for expression of viral NP. Data represent the mean percent infection (±1 SD) from a
minimumof 4 independentﬁelds per chamber. (B)Monolayers of PECMϕwere incubated
with 106 PFU of BJ WT or BJpp1-BJpp3 viruses for 5 min, washed, and incubated for a further
7 h. At this time, cells were ﬁxed and stained by immunoﬂuorescence for viral NP. Data
represents the mean percent infection (±1 SD) from a minimum of 4 independent ﬁelds
per chamber. For panels A and B, *=BJWT is signiﬁcantly increased compared to all other
groups, pb0.01, one-way ANOVA.
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sensitivity of BJx109viruses toneutralizationbymousebronchoalveolar
lavage (BAL) ﬂuid. First, dilutions of BAL were incubated with virus andFig. 3. Neutralization of BJWT and BJ186 by mouse airway ﬂuids. (A) BJWT or BJpp1-BJpp3 viru
incubated for 30 min at 37 °C and added to LA-4 cell monolayers. The amount of infectious vir
of neutralization by mannan (+mannan) was examined by adding mannan (to a ﬁnal conce
of BAL in TBS containing 10 mM CaCl2 (Buffer) were added to LA-4 cell monolayers and inc
incubation for 1 h at 37 °C, the inoculum was removed and the amount of infectious virus re
neutralization by mannan (+mannan) was examined by adding mannan (to a ﬁnal concentr
indicates dilutions at which BJWT is signiﬁcantly more sensitive to BAL compared to BJpp virthe amount of infectious virus remaining was determined on LA-4 cell
monolayers (Fig. 3A, upper panel). BAL ﬂuids neutralized BJWT and BJ186
to equivalent levels and a signiﬁcant proportion of the neutralizing
activity was reversed by the inclusion of mannan (Fig. 3A, lower panel).
These ﬁndings are consistent with SP-D (or a related mannose-binding
lectin) being the major neutralizing activity against BJx109 in mouse
BAL. The S186I substitution did not result in loss or gain of N-linked
glycosylation onHA, consistentwith ourﬁndings that BJWT and BJ186 are
equally sensitive to neutralization.
We hypothesized that in the lung, the enhanced binding of BJ186
viruses to mouse airway epithelial cells might increase resistance to
neutralization by innate immuneproteins inmouse lung.We therefore
performed a modiﬁed neutralization assay in which dilutions of BAL
were added to LA-4 cell monolayers prior to the addition of virus, in an
effort to mimic the microenvironment of the lung where the res-
piratory epithelium would be lined by pulmonary surfactant. Com-
pared to BJWT, we consistently observed a reduced sensitivity of BJ186
to neutralization bymouse BAL (Fig. 3B, upper panel).Mannanblocked
the neutralizing activity of mouse BAL against BJWT in the modiﬁed
neutralization assay (Fig. 3B, lower panel).
Enhanced virulence of BJ186 viruses in mice is associated with increased
virus replication
Mice infectedwith 105 PFU of plaque-puriﬁed viruseswereweighed
daily and monitored for signs of disease. Infection with BJWT did not
induce signiﬁcant weight loss over the 10-day monitoring period,
whereas BJ186-infected mice lost weight rapidly and all mice were
euthanized 7–8 days post-infection (Fig. 4A). At the time of death, BJ186-
infected mice displayed hunched posture and laboured breathing,
indicative of viral pneumonia. A number of parameters associated with
inﬂammation anddiseasewere analyzed inB6mice infectedwith either
BJWT or BJ186. As all pp BJ186 viruses showed enhanced virulence
(Fig. 4A),wehaveused a single BJ186 virus (BJpp1, hereafter referred to as
BJ186) to study these parameters in detail.
Mice infected with 105 PFU of BJWT or BJ186 were killed at days 3
and 7 post-infection and titers of infectious virus were determined in
the upper (nasal tissues) and lower (lung) respiratory tract (Fig. 4B).
At day 3, viral titers were signiﬁcantly higher in both the lungs (upperses were mixed with dilutions of mouse BAL in TBS containing 10 mM CaCl2 (Buffer),
us remaining was determined by ﬂuorescent focus assay at 8 h post-infection. Inhibition
ntration of 10 mg/mL) to BAL dilutions 20 min before the addition of virus. (B) Dilutions
ubated for 20 min at 37 °C before the addition of BJWT or BJpp1-BJpp3 viruses. Following
maining was determined by ﬂuorescent focus assay at 8 h post-infection. Inhibition of
ation of 10 mg/mL) to BAL dilutions 20 min before the addition of virus. The dashed line
uses (pb0.01, one-way ANOVA).
Fig. 4. Intranasal infection of mice with BJ186 viruses is associated with increased
virulence and virus replication. (A) Groups of 5 mice were infected with 105 PFU of BJWT
or BJpp1-BJpp3. Mice were observed daily for weight loss (upper panel). Mice which had
lost ≥25% of their original body weight were euthanized. Data represents the mean %
weight change±1 SEM. Survival plots are shown (lower panel). (B) Groups of 5 mice
were infected with 105 PFU of BJWT or BJpp1 (BJ186) and at days 3 and 7 post-infection
mice were killed and titers of infectious virus in lung (upper panel) and nasal tissue
homogenates (lower panel) were determined by plaque assay on MDCK cells. Bars
represent the mean viral titer from a group of 5 mice±1 SD. The detection limit of the
assay (0.9) is indicated by the dotted line. *=virus titers from BJ186-infected mice were
signiﬁcantly higher than those from BJWT-infected mice, pb0.01, one-way ANOVA.
Fig. 5. Infection of mice with BJ186 virus is associated with severe pulmonary pathology.
Groups of 10 B6mice were infected with 105 PFU of BJWT or BJ186 (BJpp1) and were killed
and analyzed at day 7 post-infection. (A) Representative images of inﬂammation in
H&E-stained lung sections. Lung sections from naïve mice and mice 5 days after
intranasal infection with 105 PFU of PR8 are included for comparison. Images are shown
at 10× magniﬁcation. (B) Histopathological scores for lung sections from BJx109-
infected mice. Lung sections were scored blind for alveolitis and peribronchiolar
inﬂammation from 0 to 5. Data shown represent scores from individual mice (as
indicated by circles) and median values (as indicated by bar) obtained from 1 of 3
independent readers. Samples were compared for statistical signiﬁcance using the
Kruskal–Wallis test (nonparametric). For each reader, signiﬁcant differences were
observed in histopathology scores between mice infected with BJWT compared to BJ186
mice (pb0.05, for alveolitis and peribronchiolar inﬂammation).
132 M.D. Tate et al. / Virology 413 (2011) 128–138panels) and nasal tissues (lower panels) of mice infected with BJ186
(~500-fold and ~30-fold increases in the lungs and nasal tissues,
respectively). By day 7, BJWT-infected mice had cleared virus from the
airways, whereas high titers were recovered from the lungs and nasal
tissues of BJ186-infected mice.
Infection of B6 mice with BJ186 is associated with the development of
severe pulmonary inﬂammation
We examined lung sections from mice infected 7 days previously
with either BJWT or BJ186. Lung sections from naïve animals or miceinfected 5 days earlier with the mouse-adapted PR8 virus were
included for comparison. Few inﬂammatory cells were evident in
sections from naïve (Fig. 5A-i) or BJWT-infected mice (Fig. 5A-ii),
whereas infectionwith BJ186 (Fig. 5A-iii) was associatedwith an inﬂux
of inﬂammatory cells and a pulmonary pathology similar that asso-
ciated with severe disease during PR8 infection (Tate et al., 2010b)
(Fig. 5A-iv). Lung sections were blinded, randomized and scored by 3
independent readers for alveolitis (Fig. 5B-i) and peribronchiolar
inﬂammation (Fig. 5B-ii). Levels of alveolitis and peribronchiolar
inﬂammation scored were not statistically different (i) between
naïve and BJWT-infected mice, or (ii) between BJ186 and PR8-infected
mice; however, both alveolitis and peribronchiolar inﬂammation
were signiﬁcantly higher in mice infected with BJ186 compared to
mice infected with BJWT.
Increased cellularity and production of inﬂammatory mediators in the
airways of mice infected with BJ186
Flow cytometry was used to analyze the cellular inﬁltrate in the
airways of mice infected with either BJWT or BJ186. Infection with BJWT
induced a modest recruitment of leukocytes to the airways at days 3
and 7 post-infection (Fig. 6A), whereas BAL cell numbers were sig-
niﬁcantly higher from mice infected with BJ186. Neutrophils pre-
dominated in the airways 3 days after infection with BJ186 and
numbers of NK cells, total T cells, CD8+ T cells and B220+ lymphocytes
Fig. 6. Increased cellularity and production of inﬂammatory mediators in the airways of
BJ186-infectedmice. Groups of 5micewere infectedwith 105 PFUof BJWT or BJ186. At days 3
and 7 post-infection mice were killed and analyzed. Naïve mice were included for
comparison. (A) Total numbers of BAL cells were determined by viable cell counts.
*=signiﬁcantly increased compared to BJWT-infected mice, pb0.01, one-way ANOVA.
(B) BAL cells were examined by ﬂow cytometry for the presence of neutrophils (Gr-1high),
NK cells (NK1.1+ TCRβ−), B cells (B220+), T cells (TCRβ+) and CD8+ T cells (CD8+
TCRβ+). Bars represent themean cell number±1 SD. *=cell numbers fromBJ186-infected
mice that signiﬁcantly higher compared to BJWT-infected mice, pb0.05, one-way ANOVA.
(C) Concentrations of IL-6, IFN-γ, MCP-1 and TNF-α in cell-free BAL supernatants were
determined by cytokine bead array at day 7 post-infection. Bars represent the mean
concentration (pg/ml) and individualmice are shownas circles. The detection limit of each
mediator is 5 pg/ml and is indicated as a dotted line. *=levels from BJ186-infected mice
that were signiﬁcantly elevated compared to BJWT-infected mice (pb0.05, one-way
ANOVA).
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NK cells, T cells, CD8+ T cells and B220+ lymphocytes were elevated
in BJ186-infectedmice at day 7 post-infection and CD8+ T cell numbers
were ~13-fold higher compared BJWT-infected mice, indicating major
differences in leukocyte recruitment.
Next, we determined levels of soluble inﬂammatory mediators in
BAL ﬂuids from naïve mice or from mice infected with BJWT or BJ186.
Levels of IL-6, MCP-1, IFN-γ and TNF-αwere not signiﬁcantly different
in BAL from naïve animals compared tomice infected with BJWT at day
3 (data not shown) or day 7 post-infection (Fig. 6C). In contrast, levels
of IL-6, MCP-1, TNF-α and IFN-γ in BAL from BJ186-infected mice were
signiﬁcantly increased compared to animals infected with BJWT at day
7 post-infection.Vascular leak, pulmonary edema and systemic responses associated with
severe disease in mice infected with BJ186
Vascular leak and pulmonary edema are associated with lung
diseases such as ARDS (Luh and Chiang, 2007) aswell aswith the severe
disease observed following neutrophil depletion of inﬂuenza virus-
infected mice (Tate et al., 2009) or CL-LIP-treatment of BJx109-infected
mice (Tate et al., 2010b). Levels of total protein in BAL supernatants
from BJWT or BJ186-infected mice were therefore determined at day 7
following infection as a measure of vascular leak. Total protein in BAL
from BJ186-infectedmicewas ~4-fold higher compared to BJWT-infected
mice (Fig. 7A) and the lung wet:dry ratio (Fig. 7B), a measure of
extravascular water (Xing et al., 1993), was also signiﬁcantly higher for
BJ186-infected animals.Systemic manifestations such as leukopenia and thymic atrophy
are associated with severe clinical disease during inﬂuenza infections
in humans andmice (Fislova et al., 2009; Peiris et al., 2004; Ryan et al.,
2000; Tumpey et al., 2000; Wyde et al., 1977). The severe disease
observed in BJ186-infectedmice was associatedwith reduced numbers
CD45+ blood leukocytes and circulating neutrophils, B220+ lympho-
cytes and CD8+ T cells were signiﬁcantly reduced compared to
animals infected with BJWT (Fig. 7C). Furthermore, ﬂow cytometric
analysis of thymic cell showed a marked reduction in the number of
double positive (DP) thymocytes recovered from BJ186-infected mice
compared to animals infected with BJWT (Fig. 7D). Numbers of double
negative (DN, CD4− CD8−) thymocytes were also reduced in BJ186-
infected animals, whereas a modest increase in single positive (SP,
CD4+ or CD8+) cells was observed. Immature CD4+ CD8+ DP thy-
mocytes are particularly sensitive to glucocorticosteroids induced
as part of the stress response to severe viral infection (Herold et al.,
2006). Depletion of DP thymocytes is accompanied by enhanced
numbers of SP cells in a number of viral infections (Hayasaka et al.,
2007; Onodera et al., 1991), although the mechanisms underlying this
are not clear.
A reverse genetics virus bearing the S186I substitution in the viral HA
shows enhanced virulence in mice
To verify that substitution S186I in the viral HAwas responsible for
the enhanced virulence of ppBJ186 viruses, reverse genetics (RG) was
used to generate 6:2 reassortant viruses expressing the HA and NA of
A/Beijing/353/89 (Beij/89; H3N2) and all internal components
derived from PR8. RG viruses expressing WT Beij/89 HA (RG-BJWT)
or Beij/89 HA containing the S186I substitution (RG-BJ186) were
rescued, ampliﬁed in once in eggs and characterized in vitro and in
vivo. Sequencing of RNA extracted from allantoic ﬂuid conﬁrmed
that amino acid substitution S186I was retained and that no other
substitutions had been introduced in HA or NA.
We conﬁrmed that RG-BJ186 (i) agglutinated horse erythrocytes
expressing α(2,3)-Gal-linked Neu5Gc, whereas RG-BJWT did not (data
not shown), and (ii) was less efﬁcient in its ability to infect murine Mϕ
(Supplementary Fig. 1A).Moreover, inoculation ofmicewith 105 PFU of
RG-BJWT did not result in any weight loss over a 10-day monitoring
period, whereas mice infected with an equivalent dose of RG-BJ186 lost
weight rapidly and all succumbed to disease (Supplementary Fig. 1B).
Together, these data conﬁrm that RG-BJWT and RG-BJ186 behaved
similarly to BJWT and BJ186 in vitro and in vivo. Thus, amino acid sub-
stitution S186I in Beij/89 HA is associated with altered receptor
speciﬁcity and virulence in mice.
Discussion
Egg-adapted human H3 viruses show enhanced binding to α(2,3)-
Gal-linked SA present on the chicken embryo chorioallantoic mem-
brane (CAM), unlike non-adapted counterparts, which show a pref-
erence for α(2,6)-Gal-linked SA (Gambaryan et al., 1999; Gambaryan
et al., 1997; Ito et al., 1997b). The S186I substitution has been noted
following adaptation of H3 subtype inﬂuenza viruses to eggs, re-
sulting in increased afﬁnity for α(2,3)-Gal-linked-SA (Gambaryan
et al., 1999; Gambaryan et al., 1997; Matrosovich et al., 1998). Other
substitutions, for example G186V, have also been associated with
adaptation of H3 viruses to growth in eggs (Lu et al., 2005; Widjaja
et al., 2006). Pig serum (PS) is a rich source of α-macroglobulin
which expresses high levels of α(2,6)-Gal-linked SA (Ryan-Poirier
and Kawaoka, 1993) and selection of a PS-resistant mutant of
A/Los Angeles/2/87 (H3N2) was associated with the S186I substitu-
tion in HA (Matrosovich et al., 1998; Ryan-Poirier and Kawaoka,
1991). Moreover, resistance to the PS inhibitor was associated with
poor recognition of α(2,6)-Gal-linked SA (Gimsa et al., 1996;
Matrosovich et al., 1998). In our studies, BJ186 viruses retained the
Fig. 7. Severe disease during BJ186 infection of B6 mice is associated with pulmonary edema, leukopenia and thymic atrophy. Groups of 5 mice infected with 105 PFU of BJWT or BJ186
virus were euthanized and analyzed for pulmonary and systemic manifestations of disease at day 7 post-infection. Naïve mice were included for comparison. (A) Total protein
concentration in cell-free BAL supernatants. Data shown represent the mean protein concentration±1 SD. (B) Lung wet-to-dry ratios as an assessment of pulmonary edema. For
panels A/B, *=signiﬁcantly increased when compared to naïve mice, pb0.05, one-way ANOVA. (C) Viable cell counts were performed on whole blood and ﬂow cytometry was used
to determine numbers of CD45+ inﬂammatory (inﬂam) cells, neutrophils (Gr-1high, neut), CD4+ cells (CD4+ TCRβ+), CD8+ T cells (CD8+ TCRβ+) and B220+ cells (B cells).
*=numbers from BJ186-infected mice were signiﬁcantly reduced compared BJWT-infected mice (pb0.05, one-way ANOVA). (D) Viable cell counts were performed on single cell
suspensions prepared from mouse thymi and ﬂow cytometry was used to determine numbers of double negative (CD4− CD8−, DN), double positive (CD4+ CD8+, DP) and single
positive (CD4+ or CD8+, SP) thymocytes. *=cell numbers signiﬁcantly elevated or reduced compared to mice infected with BJWT (pb0.05, one-way ANOVA).
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Neu5Ac but acquired recognition of α(2,3)-Gal-linked Neu5Ac
(Table 1).
We propose that the ability of BJ186 viruses to recognize α(2,3)-
Gal-linked SA is likely important in enhancing infection of mouse
airway epithelial cells and therefore virulence. Compared to BJWT,
BJ186 showed increased ability to bind α(2,3)-Gal-linked Neu5Ac
(Table 1) and infected LA-4 mouse epithelial cells with greater
efﬁciency (Fig. 1). Furthermore, BJ186 bound efﬁciently to LA-4 cells at
4 °C but were poor in their ability to elute from the cell surface at 37 °C
(Fig. 1C), likely reﬂecting a disruption in HA/NA balance due to
increased afﬁnity for α(2,3)-Gal-linked SA which is abundantly
expressed on LA-4 cells (Tate et al., 2011). BJ186 replicated to high
titers in mouse lung following intranasal infection (Fig. 4B), yet lower
titers of BJ186 were detected in cell-free supernatants collected from
LA-4 cells at 16–48 h post-infection (Fig. 1D). In vivo, virus released
from BJ186-infected cells will infect additional epithelial cells, leading
to virus ampliﬁcation in the lung. In vitro, multiple rounds of virus
infection and ampliﬁcation will be limited by the number of
susceptible LA-4 target cells available. Moreover, the enhanced ability
of BJ186 to bind to the surface of LA-4 cells would suggest that
following cytolytic infection, virus releasedmay bind to cellular debris
including plasma membranes, and would therefore be removed by
centrifugation prior to plaque assay.
Our previous studies have demonstrated that airwayMϕ expresses
high levels of α(2,6)-Gal-linked SA compared to α(2,3)-Gal-linked SA
(Tate et al., 2011). The S186I substitution of BJ186 was associated with
reduced infection of Mϕ; however, BJ186 and BJWT were equally
efﬁcient at agglutinating erythrocytes bearing α(2,6)-Gal-linked
Neu5Ac (Table 1). Our ﬁndings would be consistent with the notion
that subtle differences in ﬁne speciﬁcity of the receptor-binding site of
BJ186 viruses promote less efﬁcient binding to sialylated species
expressed on theMϕ surface. Alternatively, S186Imay disrupt the HA/
NA balance to impede efﬁcient attachment to theMϕ surface resulting
in less efﬁcient entry and infection via the macrophage mannose
receptor (MMR).BJx109 is sensitive to neutralization by collectins, including SP-D in
mouse airway ﬂuids (Reading et al., 1997; Tate et al., in press).
Previous studies have shown that resistance to β-inhibitors, including
SP-D, was associatedwith loss of glycosylation site Asn165 from the HA
of A/Philippines/2/82 (Anders et al., 1990; Hartley et al., 1992) and
increased virulence in mice (Hartley et al., 1997). Loss of Asn246 from
Beij/89 HA was also associated with resistance to SP-D and enhanced
virulence (Reading et al., 2009) and addition of N-linked glycosyla-
tion sites to HA resulted in H3 viruses that were more sensitive to
SP-D and less virulent in mice (Vigerust et al., 2007). Residue 186 is
located in the vicinity of the receptor-binding pocket and the S186I
mutation does not add or delete an N-linked glycans from HA.
Consistent with this, whenmixed with mouse BAL prior to addition to
LA-4 cell monolayers, BJWT and BJ186 were neutralized to similar levels
(Fig. 3A). However, addition of mouse BAL to LA-4 cells (therefore
mimicking the function of pulmonary surfactant in the airways) prior
to virus addition showed that BJ186 was more efﬁcient at infecting
LA-4 cells in the presence of BAL (Fig. 3B). These results are of
particular interest when considering the dilute nature of mouse BAL
compared to the concentrations of inhibitory proteins present in pul-
monary surfactant in vivo. Thus, while BJWT and BJ186 were equivalent
in their sensitivity to neutralization by mouse BAL per se (as demon-
strated by pre-mixing of each virus with mouse BAL), the enhanced
ability of BJ186 to bind and infect murine airway epithelial cells may
reduce the effectiveness of SP-D-mediatedneutralization in vivo as BJ186
can infect epithelial cells more rapidly, therebyminimizing its exposure
to innate immune proteins present in airway ﬂuids.
Infection of mice with BJ186 led to severe disease, characterized by
enhanced viral replication in the respiratory tract (Fig. 4B), severe
pulmonary inﬂammation (Figs. 5 and 6) and ARDS-like disease
associated with vascular leak and pulmonary edema (Fig. 7A/B).
Mouse-adapted viruses such as PR8 have a receptor preference for
α(2,3)-Gal-linked SA over α(2,6)-Gal-linked SA (Hensley et al., 2009;
Suzuki et al., 1986; Tate et al., 2011) and mouse-virulent BJ186 had
acquired the ability to agglutinate erythrocytes expressing α(2,3)-
Gal-linked Neu5Ac (Table 1) and horse erythrocytes expressing
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high levels in the lungs of mice (Hedlund et al., 2007; Makatsori et al.,
1998; Markotic et al., 1999), suggesting that enhanced binding to
α(2,3)-Gal-linked Neu5Ac and/or α(2,3)-Gal-linked Neu5Gc is likely
to contribute to the increased virulence of BJ186. Avian inﬂuenza
viruses also display receptor preference for α(2,3)-Gal-linked SA
(Connor et al., 1994; Matrosovich et al., 1997) and some strains can
induce a severe ARDS-like disease in mice without prior adaptation
(Deng et al., 2010; Xu et al., 2006).
Together, data presented in this study highlight the importance of
receptor speciﬁcity in affecting the ability of inﬂuenza virus to interact
with components of innate host defense and in determining disease
severity. Previous studies have clearly deﬁned the relationship
between glycosylation of HA, sensitivity to collectins and virulence
in mice (Reading et al., 1997; Vigerust et al., 2007). Data presented
herein demonstrate that changes in receptor speciﬁcity that do not
alter HA glycosylation also modulate virulence. During adaptation of
human virus strains to growth in mice, a receptor switch to pref-
erential recognition of α(2,3)-Gal-linked SA is likely to enhance
infection of mouse epithelial cells and may also to increase resistance
to innate immune defenses in mouse lung.
Materials and methods
Mice and viruses
C57BL/6 (B6)mice were bred and housed in speciﬁc pathogen-free
conditions at the Department of Microbiology and Immunology,
University of Melbourne. Male mice 6–8 weeks of age were used in all
experiments. The inﬂuenza virus strains A/PR/8/34 Mount Sinai (PR8,
H1N1) and BJx109 (H3N2) were obtained from the WHO Collaborat-
ing Centre for Reference and Research on Inﬂuenza, NorthMelbourne,
Australia. BJx109 is a high-yielding reassortants of PR8 with A/Beijing/
353/89 (H3N2) that bears that H3N2 surface glycoproteins.
Inﬂuenza viruses were grown in 10-day embryonated eggs by
standard procedures and titrated by plaque assay under agarose using
Madin–Darby canine kidney (MDCK) cells (Anders et al., 1994). Due
to differences noted in the plaque size of BJWT and BJ186 viruses (see
Results), titers of infectious virus were conﬁrmed using a single-cycle
ﬂuorescent focus assay where monolayers of MDCK cells were
infected with serial dilutions of each virus. After 1 h, the inoculum
was removed and replaced with serum-free media. At 6–8 h post-
infection, cell monolayers were washed and ﬁxed in 80% acetone in
water, and inﬂuenza virus-infected cells were detected using mAb
clone MP3.1092.IC7 for detection of inﬂuenza virus nucleoprotein
(NP; WHO Collaborating Centre for Reference and Research on
Inﬂuenza, Melbourne, Australia), followed by FITC-conjugated sheep
anti-mouse Ig (Silenus, Australia).
Isolation of small plaque mutant of BJx109 from the lungs of mice
Mice were depleted of airway Mϕ via intranasal treatment with
100 μl of clodronate-loaded liposomes (CL-LIP; Roche Diagnostics,
Germany) while under light anesthesia with isoﬂurane. Mice were
treated 48 h prior to infection with 105 PFU of BJx109 and every 72
h thereafter as described (Tate et al., 2010b). Control mice received an
equivalent volume of PBS or saline-loaded liposomes (SL-LIP). At day
7 following infection, mice were euthanized; lungs were removed and
homogenised; and titers of infectious virus in clariﬁed homogenates
were determined by plaque assay on MDCK cell monolayers in the
presence of trypsin (Anders et al., 1994). For plaque puriﬁcation (pp),
5 well-separated plaques were picked from 3 different CL-LIP-treated
mice, resuspended in PBS and inoculated into 10-day embryonated
hens' eggs. Allantoic ﬂuid was harvested and frozen at −70 °C.
The genes encoding viral HA and NA glycoproteins were examined
for nucleotide changes. RNA was extracted from allantoic ﬂuid cellpellet using RNeasy Minikit (Qiagen, USA). Synthesis of cDNA from
RNA served as a template for subsequent PCR reactions preformed
with Qiagen Omniscript RT kit using 20 pmol/μL of Uni12 primer (AGC
AAA AGC AGG). DNA encoding the HA and NA genes was ampliﬁed
by PCR using primers as described (Hoffmann et al., 2001). PCR
products were analyzed by agarose gel electrophoresis and bands of
speciﬁc size were extracted using gel extraction kit (MO BIO, USA).
Sequencing was performed by Applied Genetics Diagnostics, Depart-
ment of Pathology, The University of Melbourne. H3 numbering
(Nobusawa et al., 1991) was used to align the deduced amino acid
sequences.
Reassortant inﬂuenza viruses used in this study were generated by
8-plasmid reverse genetics (RG) as previously described (Hoffmann
et al., 2002). Viruses generated were 6:2 reassortants consisting of the
6 gene ‘PR8 backbone’ with HA and NA genes from Beij/89. Plasmid
vectors (pHW2000) containing the 6 genes of PR8 were kindly
provided by Dr. Robert Webster, St. Jude Children's Research Hospital,
Memphis, TN, USA. A plasmid on the pHW2000 backbone carrying the
HA of A/Beijing/353/89 (Beij/89, H3N2) was altered to express S→ I at
residue 186 (H3 numbering) via site-directed mutagenesis using
cloned Pfu DNA polymerase (Stratagene, USA). Parental template was
then digested via incubation with DpnI (New England Biolabs, USA).
Viruses generated were 6:2 reassortants consisting of the PR8 (H1N1)
‘backbone’with the HA and NA genes from Beij/89. RG viruses bearing
the HA of Beij/89 (RG-BJWT) or S186I HA (RG-BJ186) were recovered
after 3 days and ampliﬁed in the allantoic cavity of 10-day-old
embryonated hens’ eggs. The HA of RG viruses was sequenced to
ensure that appropriate sequences were obtained in egg-grown virus
stocks.
Desialylation and resialylation of erythrocytes
Methods for the enzymatic modiﬁcation of erythrocyte oligosac-
charides have been described previously (Rogers and Paulson, 1983).
In brief, suspensions (10%) human erythrocytes were desialylated
with 600 mU/ml of C. perfringes sialidase for 1 h at 37 °C, washed
twice and resialylated using 1.5 mM CMP-N-acetylneuraminic acid
(NeuAc, Sigma-Aldrich) and 4 mU of either β-galactoside-α2,3-
sialyltransferase (α(2,3)-ST, Japan Tobacco Inc., Shizuka, Japan) or
β-D-Galactosyl-β1,4-N-acetyl-β-D-glucosamine-α2,6-sialyltransferase
(α(2,6)-ST,Merck, USA) in 100 μl, orwithbuffer alone (sham treated) at
37 °C for 4 h. Erythrocytes were washed in TBS and used in standard
hemagglutination (HA) titrations.
Virus neutralization assay
To examine the ability of bronchoalveolar lavage (BAL) ﬂuids to
neutralize virus infectivity, naïve mice were euthanized and the lungs
ﬂushed three times with 1 ml of tris-buffered saline (TBS) through a
bunted 23-guage needle inserted into the trachea. BAL ﬂuids were
clariﬁed by centrifugation and supernatants frozen at−20 °C. Neutral-
ization of inﬂuenza virus infectivity was measured by ﬂuorescent
focus reduction in monolayers of LA-4 cells cultured in 96-well
plates as described (Reading et al., 1997). Brieﬂy, BAL supernatants
were diluted in TBS supplemented with 10 mM CaCl2 and incubated
with a constant amount of virus for 30min prior to the addition to cell
monolayers. In some experiments, dilutions of BAL supernatants were
added to cell monolayers prior to the addition of virus. Inﬂuenza virus-
infected cells were detected as described above in the single-cycle
ﬂuorescent focus assay. The total number of ﬂuorescent foci in four
representative ﬁelds was counted and expressed as a percentage of
the number of foci in the corresponding area of duplicate control
wells infected with virus alone (i.e. percent of virus control). To test
for inhibition by mannan, diluted BAL supernatant was incubated
with mannan for 30 min at room temperature prior to the addition
of virus.
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Mouse peritoneal exudate cell (PEC) Mϕ or the murine LA-4 lung
epithelial cell line was prepared and infected with virus in 8-well
chamber slides as previously described (Reading et al., 2000). Slides
were stained for expression of inﬂuenza virus NP as described above
andwith 10 μg/ml propidium iodide (Sigma-Aldrich, USA) to visualize
nuclei of adherent cells and therefore determine total cell number.
The number of ﬂuorescent and total cells was counted in a minimum
of four random ﬁelds with a minimum of 200 cells counted for each
sample and used to determine the percent of cells infected by virus.
To test for inhibition of infection by mannan, cells were incubated
with mannan (ﬁnal concentration 10 mg/ml) for 30 min at room
temperature before addition of virus. In some experiments, LA-4 cells
were infected in chamber slides with 0.01 PFU/cell of virus, washed
and cultured in serum-free media in the presence of 4 μg/ml TPCK-
treated trypsin. Supernatants were removed at 2, 8, 16, 24 and 48 h
post-infection and clariﬁed by centrifugation and the viral titer (PFU/
ml) was determined by plaque assay on MDCK cell monolayers.
Virus binding and elution from epithelial cells
The ability of inﬂuenza virus to bind and elute from the surface of
LA-4 cells was performed as described (Reading et al., 2009). Brieﬂy,
128 hemagglutinating units (HAU) of inﬂuenza virus was added to
duplicate tubes, each containing 106 LA-4 cells pre-ﬁxedwith 2% (v/v)
PFA. Both samples were incubated on ice for 60 min and then one
samplewas held at 4 °C, while the duplicate samplewas transferred to
37 °C for 30 min. A third tube received no cells and was held at 4 °C
throughout. Samples were centrifuged and virus remaining in cell
supernatant was quantiﬁed by standard HA assay and expressed as
HAU.
Virus infection of mice
Mice were anesthetized and infected with 105 PFU of inﬂuenza
virus via the intranasal (i.n.) route in 50 μl of PBS. Mice were weighed
daily and assessed for visual signs of clinical disease including
inactivity, rufﬂed fur, laboured breathing and huddling behavior.
Animals that had lost ≥25% of their original body weight and/or
displayed evidence of pneumonia were euthanized. All research
complied with the University of Melbourne's Animal Experimentation
Ethics guidelines and policies. At various times after infection, mice
were euthanized and the lungs and nasal tissues were removed,
homogenised in PBS and clariﬁed by centrifugation. Titers of
infectious virus in tissue homogenates were determined by standard
plaque assay on MDCK cells.
Recovery and characterization of leukocytes from mice
BAL cells and heparinized blood were obtained as described (Tate
et al., 2008). Samples were treated with Tris–NH4Cl (0.14 M NH4Cl in
17 mM Tris, adjusted to pH 7.2) to lyse erythrocytes and washed in
RPMI 1640 medium supplemented with 10% FCS (RF10). Cell numbers
and cell viability were assessed via trypan blue exclusion.
For ﬂow cytometric analysis, single cell suspensions prepared from
the blood, BAL and thymus were incubated on ice for 20 min with
supernatants from hybridoma 2.4G2 to block Fc receptors, followed by
staining with appropriate combinations of ﬂuorescein isothiocyanate
(FITC)-, phycoerythrin (PE)-, allophycocyanin (APC)-conjugated to
Gr-1 (RB6-8C5), CD45.2 (104), CD8a (53–6.7), CD4 (GK1.5), B220
(RA3-6B2), TCRβ (H57-597) and NK1.1 (PK136). Living cells were
analyzed by the addition of 10 μg/ml PI to each sample and cells were
analyzed using a FACSCalibur ﬂow cytometer. A minimum of 50,000
live cells (PI−) were collected.Pulmonary histopathology
Lungs were perfused, inﬂated and ﬁxed in a solution of 4%
formaldehyde as previously described (Tate et al., 2009), before 4 μm
sections were prepared and stained with hematoxylin and eosin
(H&E). Airway inﬂammation of H&E-stained lung sections was eval-
uated on a subjective scale of 0–5 (0=no inﬂammation, 1=very
mild, 2=mild, 3=moderate, 4=marked and 5=severe inﬂamma-
tion) by three independent readers, as described (Tate et al., 2009).
Sections were blinded and randomized and samples corresponding
to the least severe and most severe inﬂammation were assigned
scores of 0 and 5, respectively. All samples were then graded for
peribronchiolar inﬂammation (around 3–5 small airways per section)
and alveolitis in multiple random ﬁelds per section by three
independent readers as described (Sur et al., 1999). Lung sections
were viewed on a Leica DMI3000 B microscope and photographed at
100× magniﬁcation unless otherwise stated using a Leica DFC 490
camera running from the Leica Application software.
Cytokine bead array for the detection of inﬂammatory mediators
The levels of IFNγ, TNFα, IL-6, IL-10, IL-12.p70 and MCP-1 in BAL
supernatants and serum were determined with the use of a cytokine
bead array mouse inﬂammation kit (Becton Dickinson, USA) accord-
ing to the manufacturer's instructions. The detection limit for the
assay was 5 pg/mL for all cytokines tested.
Assessment of lung edema and vascular leak
The lung wet-to-dry weight ratio was used as an index of lung
water accumulation during inﬂuenza virus infection. Lungs were
surgically dissected, blotted dry and weighed immediately (wet
weight). The lung tissue was then dried in an oven at 60 °C for 72 h
and re-weighed as dry weight. The ratio of weight-to-dry was
calculated for each animal to assess tissue edema as previously
described (Whitehead et al., 2006). The concentration of protein in
cell-free BAL supernatant was measured by adding Bradford protein
dye. A standard curve using BSA was constructed and the OD
determined at 595 nm.
Statistical analysis
For the comparison of two sets of values, a Student's t test (two-
tailed, two-sample equal variance) was used. When comparing three
or more sets of values, data were analyzed by one-way ANOVA
(nonparametric) followed by post-hoc analysis using Tukey'smultiple
comparison test. For the analysis of histopathological data, a Kruskal–
Wallis test (nonparametric) was used followed by the Dunn's post-
test. Survival proportions were compared using the Mantel Cox log
rank test. A p value of ≤0.05 was considered statistically signiﬁcant.
Supplementarymaterials related to this article can be found online
at doi: 10.1016/j.virol.2011.01.035.
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